ARCHIVES

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 40 | November 2, 2007

Download PDF Visit The Full Archive

Related Articles

Schmidt Already Working For NIH Despite His Opposition To Kennedy’s New Research Panel

April 5, 1974

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991

Mortality, Survival Still Improving for Whites, Remain Static Or Decline For Blacks; Largest Survival Increase For Whites In history Of SEER Program

June 2, 1989

Program Committee Lists 10 Papers At AACR Meeting

July 19, 1985

Interview: Burzynski Explains Why He Calls Treatment “Non-Toxic”

September 25, 1998

Bayer’s HER-2/neu Blood Test Cleared By FDA For Marketing.

December 15, 2000